Padres' Maybin suspended 25 games for amphetamine
07/23/2014 3:41 PM
07/23/2014 3:50 PM
New York, NY (SportsNetwork.com) - San Diego Padres outfielder Cameron Maybin was suspended 25 games by Major League Baseball after testing positive for an amphetamine he says he was taking to treat attention deficit hyperactivity disorder.
The suspension, announced Wednesday, is effective immediately.
Maybin is eligible to return to the active roster on Aug. 20.
In a statement issued by the Major League Baseball Players Association, the outfielder said he's been receiving treatment for ADHD for several years and previously had a therapeutic use exemption.
"Unfortunately, in my attempts to switch back to a medicine that had been previously OK'd, I neglected to follow all the rules and as a result I tested positive," Maybin said.
"I want to assure everyone that this was a genuine effort to treat my condition and I was not trying in any way to gain an advantage in my baseball career. I understand that I must accept responsibility for this mistake and I will take my punishment and will not challenge my suspension.
"I apologize to my family, friends, fans, teammates, and the entire Padres organization. I look forward to returning to the field and contributing to the success of my club."
Maybin, 27, is batting .247 with a .286 on-base percentage, one home run and nine RBI in 62 games for the Padres this season. The eight-year MLB veteran is a career .248 hitter.
"Cameron has accepted full responsibility for his violation and apologized to his teammates and coaches," said Padres manager Bud Black. "We are all looking forward to his return."
Oops, you haven't selected any newsletters. Please check the box next to one or more of our email newsletters and submit again.
Oops, you didn't provide a valid email address. Please double-check the email field and submit again.
Join the Discussion
Miami Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere on the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.